- Details
- Description
Packaging Size:
3 capsules/pack
Strength:
125 mg / 80 mg
Composition:
Aprepitant
Treatment:
Prevention of chemotherapy-induced nausea and vomiting (CINV), including acute and delayed vomiting associated with cancer chemotherapy.
Form:
Capsule
Brand:
Aproxi
Quantity Unit:
Capsule/Box
Aproxi (Aprepitant) is an oral prescription antiemetic medicine used primarily to prevent chemotherapy-induced nausea and vomiting (CINV). It is a selective NK1 receptor antagonist that blocks substance P signaling in the brain, helping prevent both acute and delayed nausea and vomiting associated with cancer chemotherapy. Aproxi is often used in combination with other antiemetic medicines such as a 5-HT3 antagonist and dexamethasone.
